- HLBS-PopOmics -
Last Posted: Dec 13, 2018
- Polygenic risk score identifies associations between sleep duration and diseases determined from an electronic medical record biobank.
Dashti Hassan S et al. Sleep 2018 Dec
- Clinical and Experimental Human Sleep-Wake Pharmacogenetics.
Landolt Hans-Peter et al. Handbook of experimental pharmacology 2018 Nov
- New supplemental awards boost NIH funding for research on Down syndrome
NIH, October 1, 2018
- The Use of Precision Medicine to Manage Obstructive Sleep Apnea Treatment in Patients with Resistant Hypertension: Current Evidence and Future Directions.
Sapiña Esther et al. Current hypertension reports 2018 Jun 20(7) 60
- The genetics of obstructive sleep apnoea.
Mukherjee Sutapa et al. Respirology (Carlton, Vic.) 2018 Jan 23(1) 18-27
- Fragile X syndrome: an overview and update of the FMR1 gene.
Mila Montserrat et al. Clinical genetics 2017 Jun
- Greater Cognitive Deficits with Sleep-Disordered Breathing among Individuals with Genetic Susceptibility to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis.
Johnson Dayna A et al. Annals of the American Thoracic Society 2017 Jul
- Genetics of Sleep Disorders.
Gehrman Philip R et al. The Psychiatric clinics of North America 2015 Dec (4) 667-81
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Authors/Task Force Members et al. European heart journal 2015 Aug
- Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America.
Quick Links to Other Resources
Common HLBS Health Categories
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Mar 1, 2018
- Page last updated:Feb 18, 2019
- Content source: